Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04631042 · ClinicalTrials.gov registry record

Developing Brain, Impulsivity and Compulsivity

A clinical trial of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder, sponsored by National Institute of Mental Health (NIMH).

Recruiting
Registry status
1,100
Enrollment target
1
Study location

NCT04631042 is a study of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 1,100 participants, above the 130-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (746% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04631042, a study of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).

RECRUITING
Registry status
1,100 participants
Enrollment target
1
Study location

Study Summary

Background: Impulsivity is acting 'without thinking.' Compulsivity is being overly inflexible. People vary in how impulsive or compulsive they are. Extreme versions of these behaviors play a role in mental disorders. Researchers want to study changes in the brain to learn more about these behaviors. Differences in genes may also play a role. Objective: To learn about genetic \& brain features that explain why levels of impulsivity and compulsivity vary across people. Eligibility: People ages 6 - 80 Design: Participants will be screened with a medical history and medical record review. Participants will talk about their mental and behavioral development. They may discuss topics like drug use and sexual activity. They will complete surveys about their compulsivity and impulsivity. Parents of child participants may also complete these surveys. Participants may take memory, attention, and thinking tests. They may give blood or saliva samples for gene studies and they may give blood to make induced pluripotent stem cells. Participants may have their face and irises photographs taken. Participants may have a magnetic resonance imaging scan. It will take pictures of their brain. The scanner is shaped like a cylinder. Participants will lie on a table that slides in and out of the scanner. A coil will be placed over their head. They will lie still, watch a movie, and play a game. Participants may ask family members to join the study. Researchers are particularly interested in recruiting twin pairs to the study. Participants under age 25 may repeat these tests every 1-2 years until they turn 25 or until the study ends. For those over age 25, participation will last less than 1 month.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 1,100 participants
Start Date 2022-09-30
Est. Completion 2031-12-31

What the Registry Record Tells You About NCT04631042

The ClinicalTrials.gov registry entry for NCT04631042 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 130-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (746% higher). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT04631042 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04631042 about?

NCT04631042 is a clinical study titled "Developing Brain, Impulsivity and Compulsivity". Background: Impulsivity is acting 'without thinking.' Compulsivity is being overly inflexible. People vary in how impulsive or compulsive they are. Extreme versions of these behaviors play a role in mental disorders. Researchers want to study changes in the brain to learn more about these behaviors...

What is the current status of trial NCT04631042?

This trial is currently recruiting. The enrollment target is 1,100 participants. The study started on 2022-09-30. Estimated completion is 2031-12-31.

What conditions does trial NCT04631042 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Obsessive - Compulsive Disorder, Conduct Disorder, Typical Development.

Who is sponsoring clinical trial NCT04631042?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04631042 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.